当前位置: X-MOL 学术Lancet Haematol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Rituximab biosimilars for B-cell lymphomas: a decade of real-world experience from India.
The Lancet Haematology ( IF 24.7 ) Pub Date : 2021-08-01 , DOI: 10.1016/s2352-3026(21)00212-x
Reena Nair 1 , Vivek S Radhakrishnan 1 , Mohandas K Mallath 2
Affiliation  



中文翻译:

用于 B 细胞淋巴瘤的利妥昔单抗生物仿制药:来自印度的十年真实世界经验。

更新日期:2021-08-01
down
wechat
bug